GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Nr1h4 | mm39_v1_chr10_-_89369432_89369452 | 0.88 | 7.9e-13 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 24.5 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.4 | 23.8 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
3.7 | 22.1 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
2.7 | 19.2 | GO:0060332 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) heme transport(GO:0015886) positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
1.6 | 18.1 | GO:1903797 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.3 | 17.4 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
2.5 | 17.3 | GO:0046618 | drug export(GO:0046618) |
1.1 | 16.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
4.2 | 16.6 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
2.5 | 15.1 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 61.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.2 | 22.1 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
1.0 | 17.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.7 | 16.6 | GO:0042627 | chylomicron(GO:0042627) |
0.2 | 14.5 | GO:0034707 | chloride channel complex(GO:0034707) |
0.2 | 13.9 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 13.6 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 12.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 11.6 | GO:0005740 | mitochondrial envelope(GO:0005740) |
0.0 | 10.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 44.2 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.2 | 33.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 33.3 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
0.1 | 25.7 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
2.0 | 24.5 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
3.2 | 22.1 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
3.2 | 19.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 18.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.3 | 17.4 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
2.5 | 15.1 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 38.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
1.1 | 22.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.6 | 16.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 15.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 12.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 5.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 2.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 2.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 1.9 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 1.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 25.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.9 | 22.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.6 | 16.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 15.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
1.4 | 15.0 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
1.2 | 13.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 12.4 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.5 | 11.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.8 | 11.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.5 | 7.9 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |